GetTopicDetailResponse(id=55521234e96d, topicName=lerociclib, introduction=, content=乳腺癌 lerociclib, image=null, comments=0, allHits=321, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Jan 18 23:50:27 CST 2025, time=2025-01-18, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=500657, tagList=[TagDto(tagId=500657, tagName=lerociclib)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2248724, encodeId=efeb2248e24fd, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a> <a href='/topic/show?id=55521234e96d' target=_blank style='color:#2F92EE;'>#lerociclib#</a>, objectTitle=Nat Commun：中國(guó)醫(yī)學(xué)科學(xué)院徐兵河團(tuán)隊(duì)評(píng)估lerociclib在乳腺癌患者中的療效和安全性, objectType=article, longId=860092, objectId=5cb8860092d3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220801/1659324313353_8252897.webp, objectUrl=/article/show_article.do?id=5cb8860092d3, replyNumber=0, likeNumber=40, createdTime=2025-01-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=5cb8860092d3, moduleTitle=Nat Commun：中國(guó)醫(yī)學(xué)科學(xué)院徐兵河團(tuán)隊(duì)評(píng)估lerociclib在乳腺癌患者中的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5cb8860092d3)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-01-18發(fā)表于陜西省
